Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ADVR: BULLS AND BEARS! -- Ignore unavailable to you. Want to Upgrade?

To: OLD JAKE JUSTUS who wrote (5787)	5/3/1998 9:58:00 AM
From: DAN LITTLE	Read Replies (2) \| Respond to of 8902

Jake, in the last SEC filing it stated that ADVR had recieved about 4 million in financing last year. I take that to mean that the RBB deal is completed. The Yonkers lab, Argentina trials, Safety test, and wages should account for about 2 million. That leaves about 2 million in the bank. I believe that Dr. Hirschman got what he needed, with a cushion, to get this ball rolling. Now if sales can commence in Argentina, and perhaps elsewhere, no further financing will be needed. I suspect a grant is likely for the FDA process. Dan